Adial Pharmaceuticals Ownership 2024 | Who Owns Adial Pharmaceuticals Now?

Overview RevenueFinancials Chart

Institutional Ownership

8.52%

Insider Ownership

1.76%

Retail Ownership

89.72%

Institutional Holders

17.00

Adial Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-187	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-29,705	-100.00%	-	Sep 30, 2023
TRUIST FINANCIAL CORP	-	-	-	-33,862	-100.00%	-	Sep 30, 2023
MORGAN STANLEY	-	-	-	-535	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-17,623	-100.00%	-	Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-137,464	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-194,364	-100.00%	-	Sep 30, 2023
MANCHESTER CAPITAL MANAGEMENT LLC	-	-	-	-1,202,452	-100.00%	-	Sep 30, 2023
ENVESTNET ASSET MANAGEMENT INC	-	-	-	-13,088	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,691	-100.00%	-	Sep 30, 2023
VIRTU FINANCIAL LLC	-	-	-	-26,473	-100.00%	-	Sep 30, 2023
CREATIVE PLANNING	-	-	-	-10,000	-100.00%	-	Sep 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-24,046	-100.00%	-	Sep 30, 2023

Adial Pharmaceuticals's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-187	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-29,705	-100.00%	-	Sep 30, 2023
TRUIST FINANCIAL CORP	-	-	-	-33,862	-100.00%	-	Sep 30, 2023
MORGAN STANLEY	-	-	-	-535	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-17,623	-100.00%	-	Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-137,464	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-194,364	-100.00%	-	Sep 30, 2023
MANCHESTER CAPITAL MANAGEMENT LLC	-	-	-	-1,202,452	-100.00%	-	Sep 30, 2023
ENVESTNET ASSET MANAGEMENT INC	-	-	-	-13,088	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,691	-100.00%	-	Sep 30, 2023
VIRTU FINANCIAL LLC	-	-	-	-26,473	-100.00%	-	Sep 30, 2023
CREATIVE PLANNING	-	-	-	-10,000	-100.00%	-	Sep 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-24,046	-100.00%	-	Sep 30, 2023

The largest Adial Pharmaceuticals shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Adial Pharmaceuticals (ADIL), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WELLS FARGO & COMPANY/MN	-	-	-	-187	-100.00%	-	Sep 30, 2023
MORGAN STANLEY	-	-	-	-535	-100.00%	-	Sep 30, 2023
CREATIVE PLANNING	-	-	-	-10,000	-100.00%	-	Sep 30, 2023
ENVESTNET ASSET MANAGEMENT INC	-	-	-	-13,088	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-17,623	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,691	-100.00%	-	Sep 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-24,046	-100.00%	-	Sep 30, 2023
VIRTU FINANCIAL LLC	-	-	-	-26,473	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-29,705	-100.00%	-	Sep 30, 2023
TRUIST FINANCIAL CORP	-	-	-	-33,862	-100.00%	-	Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-137,464	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-194,364	-100.00%	-	Sep 30, 2023
MANCHESTER CAPITAL MANAGEMENT LLC	-	-	-	-1,202,452	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Adial Pharmaceuticals's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.19K stocks of ADIL, valued at -.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MANCHESTER CAPITAL MANAGEMENT LLC	-	-	-	-1,202,452	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-194,364	-100.00%	-	Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-137,464	-100.00%	-	Sep 30, 2023
TRUIST FINANCIAL CORP	-	-	-	-33,862	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-29,705	-100.00%	-	Sep 30, 2023
VIRTU FINANCIAL LLC	-	-	-	-26,473	-100.00%	-	Sep 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-24,046	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,691	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-17,623	-100.00%	-	Sep 30, 2023
ENVESTNET ASSET MANAGEMENT INC	-	-	-	-13,088	-100.00%	-	Sep 30, 2023
CREATIVE PLANNING	-	-	-	-10,000	-100.00%	-	Sep 30, 2023
MORGAN STANLEY	-	-	-	-535	-100.00%	-	Sep 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-187	-100.00%	-	Sep 30, 2023

As of Sep 30 2023, Adial Pharmaceuticals's biggest institutional seller is MANCHESTER CAPITAL MANAGEMENT LLC. The company sold -1.20M shares of ADIL, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MANCHESTER CAPITAL MANAGEMENT LLC	-	-	-	-1,202,452	-100.00%	-	Sep 30, 2023
BLACKROCK INC.	-	-	-	-194,364	-100.00%	-	Sep 30, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	-	-137,464	-100.00%	-	Sep 30, 2023
TRUIST FINANCIAL CORP	-	-	-	-33,862	-100.00%	-	Sep 30, 2023
NORTHERN TRUST CORP	-	-	-	-29,705	-100.00%	-	Sep 30, 2023
VIRTU FINANCIAL LLC	-	-	-	-26,473	-100.00%	-	Sep 30, 2023
ADVISOR GROUP HOLDINGS, INC.	-	-	-	-24,046	-100.00%	-	Sep 30, 2023
TWO SIGMA SECURITIES, LLC	-	-	-	-20,691	-100.00%	-	Sep 30, 2023
TWO SIGMA INVESTMENTS, LP	-	-	-	-17,623	-100.00%	-	Sep 30, 2023
ENVESTNET ASSET MANAGEMENT INC	-	-	-	-13,088	-100.00%	-	Sep 30, 2023
CREATIVE PLANNING	-	-	-	-10,000	-100.00%	-	Sep 30, 2023
MORGAN STANLEY	-	-	-	-535	-100.00%	-	Sep 30, 2023
WELLS FARGO & COMPANY/MN	-	-	-	-187	-100.00%	-	Sep 30, 2023

Adial Pharmaceuticals's largest sold out institutional shareholder by shares sold is MANCHESTER CAPITAL MANAGEMENT LLC, sold -1.20M shares, valued at -, as of undefined.

Adial Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	126,140	-	-	Feb 29, 2024
SCHWAB CAPITAL TRUST	0.00%	21,443	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	203,358	-	-	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	30,310	-	-	Jan 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	5,407	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	9,359	-9,359	-50.00%	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	3,176	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	1,100	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	2,336	-	-	Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	930	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	6,767	-	-	Mar 31, 2024

Adial Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 126.14K shares, compromising 0.00% of its total assets.

Adial Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 23	17	-10.53%
31 Mar, 23	19	-
31 Dec, 22	19	-5.00%
30 Sep, 22	20	-23.08%
30 Jun, 22	26	13.04%
31 Mar, 22	23	-
31 Dec, 21	23	21.05%
30 Sep, 21	19	11.76%
30 Jun, 21	17	-
31 Mar, 21	17	41.67%
31 Dec, 20	12	-7.69%
30 Sep, 20	13	44.44%
30 Jun, 20	9	-
31 Mar, 20	9	12.50%
31 Dec, 19	8	-11.11%
30 Sep, 19	9	-
30 Jun, 19	9	-25.00%
31 Mar, 19	12	50.00%
31 Dec, 18	8	60.00%
30 Sep, 18	5	-

As of 30 Jun 23, 17 institutions are holding Adial Pharmaceuticals's shares, representing a decrease of -10.53% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 23	2,253,587	-6.89%
31 Mar, 23	2,420,240	52.08%
31 Dec, 22	1,591,440	-15.48%
30 Sep, 22	1,882,923	16.72%
30 Jun, 22	1,613,169	-47.81%
31 Mar, 22	3,090,855	145.75%
31 Dec, 21	1,257,731	4.36%
30 Sep, 21	1,205,240	3.60%
30 Jun, 21	1,163,398	56.64%
31 Mar, 21	742,723	3.05%
31 Dec, 20	720,742	6.09%
30 Sep, 20	679,394	-14.24%
30 Jun, 20	792,225	28.38%
31 Mar, 20	617,082	1.85%
31 Dec, 19	605,869	0.96%
30 Sep, 19	600,122	-1.41%
30 Jun, 19	608,709	-19.99%
31 Mar, 19	760,802	177.32%
31 Dec, 18	274,342	1337.32%
30 Sep, 18	19,087	-

Adial Pharmaceuticals (ADIL) has 2.25M shares outstanding as of 30 Jun 23, down -6.89% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 23	8.52%	10.18%
31 Mar, 23	9.15%	22.64%
31 Dec, 22	6.36%	11.86%
30 Sep, 22	7.32%	16.63%
30 Jun, 22	6.63%	3.72%
31 Mar, 22	13.35%	33.25%
31 Dec, 21	6.34%	17.19%
30 Sep, 21	6.07%	13.88%
30 Jun, 21	6.61%	30.36%
31 Mar, 21	4.67%	13.96%
31 Dec, 20	5.78%	23.33%
30 Sep, 20	4.98%	10.11%
30 Jun, 20	7.02%	20.30%
31 Mar, 20	5.88%	17.65%
31 Dec, 19	5.77%	16.84%
30 Sep, 19	5.85%	16.51%
30 Jun, 19	5.95%	7.00%
31 Mar, 19	9.22%	83.40%
31 Dec, 18	3.33%	2808.14%
30 Sep, 18	0.34%	-

As of 30 Jun 23, Adial Pharmaceuticals is held by 8.52% institutional shareholders, representing a 10.18% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 23	3	-57.14%
31 Mar, 23	7	-12.50%
31 Dec, 22	8	-20.00%
30 Sep, 22	10	-33.33%
30 Jun, 22	15	50.00%
31 Mar, 22	10	42.86%
31 Dec, 21	7	-46.15%
30 Sep, 21	13	44.44%
30 Jun, 21	9	-18.18%
31 Mar, 21	11	120.00%
31 Dec, 20	5	-28.57%
30 Sep, 20	7	250.00%
30 Jun, 20	2	-33.33%
31 Mar, 20	3	50.00%
31 Dec, 19	2	-50.00%
30 Sep, 19	4	300.00%
30 Jun, 19	1	-90.00%
31 Mar, 19	10	25.00%
31 Dec, 18	8	60.00%
30 Sep, 18	5	-

3 institutional shareholders have increased their position in ADIL stock as of 30 Jun 23 compared to 7 in the previous quarter (a -57.14% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 23	6	-
31 Mar, 23	6	100.00%
31 Dec, 22	3	50.00%
30 Sep, 22	2	-33.33%
30 Jun, 22	3	-
31 Mar, 22	3	-40.00%
31 Dec, 21	5	150.00%
30 Sep, 21	2	-50.00%
30 Jun, 21	4	33.33%
31 Mar, 21	3	50.00%
31 Dec, 20	2	100.00%
30 Sep, 20	1	-
30 Jun, 20	1	-
31 Mar, 20	1	-
31 Dec, 19	-	-100.00%
30 Sep, 19	1	-66.67%
30 Jun, 19	3	200.00%
31 Mar, 19	1	-
31 Dec, 18	-	-
30 Sep, 18	-	-

6 institutional shareholders have reduced their position in ADIL stock as of 30 Jun 23 compared to 6 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 23	17	-10.53%	2,253,587	-6.89%	8.52%	10.18%	3	-57.14%	6	-
31 Mar, 23	19	-	2,420,240	52.08%	9.15%	22.64%	7	-12.50%	6	100.00%
31 Dec, 22	19	-5.00%	1,591,440	-15.48%	6.36%	11.86%	8	-20.00%	3	50.00%
30 Sep, 22	20	-23.08%	1,882,923	16.72%	7.32%	16.63%	10	-33.33%	2	-33.33%
30 Jun, 22	26	13.04%	1,613,169	-47.81%	6.63%	3.72%	15	50.00%	3	-
31 Mar, 22	23	-	3,090,855	145.75%	13.35%	33.25%	10	42.86%	3	-40.00%
31 Dec, 21	23	21.05%	1,257,731	4.36%	6.34%	17.19%	7	-46.15%	5	150.00%
30 Sep, 21	19	11.76%	1,205,240	3.60%	6.07%	13.88%	13	44.44%	2	-50.00%
30 Jun, 21	17	-	1,163,398	56.64%	6.61%	30.36%	9	-18.18%	4	33.33%
31 Mar, 21	17	41.67%	742,723	3.05%	4.67%	13.96%	11	120.00%	3	50.00%
31 Dec, 20	12	-7.69%	720,742	6.09%	5.78%	23.33%	5	-28.57%	2	100.00%
30 Sep, 20	13	44.44%	679,394	-14.24%	4.98%	10.11%	7	250.00%	1	-
30 Jun, 20	9	-	792,225	28.38%	7.02%	20.30%	2	-33.33%	1	-
31 Mar, 20	9	12.50%	617,082	1.85%	5.88%	17.65%	3	50.00%	1	-
31 Dec, 19	8	-11.11%	605,869	0.96%	5.77%	16.84%	2	-50.00%	-	-100.00%
30 Sep, 19	9	-	600,122	-1.41%	5.85%	16.51%	4	300.00%	1	-66.67%
30 Jun, 19	9	-25.00%	608,709	-19.99%	5.95%	7.00%	1	-90.00%	3	200.00%
31 Mar, 19	12	50.00%	760,802	177.32%	9.22%	83.40%	10	25.00%	1	-
31 Dec, 18	8	60.00%	274,342	1337.32%	3.33%	2808.14%	8	60.00%	-	-
30 Sep, 18	5	-	19,087	-	0.34%	-	5	-	-	-

Adial Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Oct 03, 2023	Schuyler Kevin	director	-	P-Purchase	Buy	700	$2.74	$1.92K	700

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Oct 03, 2023	Schuyler Kevin	director	-	P-Purchase	Buy	700	$2.74	$1.92K	700

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Mar 27, 2024	Gilliland Robertson H.	director	-	A-Award	Buy	12,000	$1.35	$16.20K	12,000
Mar 27, 2024	Newman James W. Jr.	director	-	A-Award	Buy	12,000	$1.35	$16.20K	12,000
Mar 27, 2024	Truluck Joseph	officer	Chief Financial Officer	A-Award	Buy	25,000	$1.35	$33.75K	25,000
Mar 27, 2024	Claiborne Cary J	director, officer	Chief Executive Officer	A-Award	Buy	60,000	$1.35	$81.00K	60,000
Mar 27, 2024	Anderson J. Kermit	director	-	A-Award	Buy	12,000	$1.35	$16.20K	12,000
Mar 27, 2024	Schuyler Kevin	director	-	A-Award	Buy	12,000	$1.35	$16.20K	12,000
Mar 27, 2024	Goodman Tony	director, officer	Chief Operating Officer	A-Award	Buy	42,000	$1.35	$56.70K	42,000
Oct 03, 2023	Schuyler Kevin	director	-	P-Purchase	Buy	700	$2.74	$1.92K	700
Jun 02, 2023	Johnson Bankole A.	director	-	A-Award	Buy	40,000	$0.30	$12.10K	40,000
May 25, 2023	Truluck Joseph	officer	Chief Financial Officer	A-Award	Buy	157,500	-	-	265,139
May 25, 2023	Truluck Joseph	officer	Chief Financial Officer	A-Award	Buy	125,000	$0.30	$37.81K	125,000
May 25, 2023	Stilley William B. III	director	-	A-Award	Buy	240,800	-	-	1,261,779
May 25, 2023	Stilley William B. III	director	-	A-Award	Buy	50,000	$0.30	$15.13K	50,000
May 25, 2023	Schuyler Kevin	director	-	A-Award	Buy	50,000	$0.30	$15.13K	50,000
May 25, 2023	Newman James W. Jr.	director	-	A-Award	Buy	50,000	$0.30	$15.13K	50,000
May 25, 2023	Goodman Tony	director	-	A-Award	Buy	50,000	$0.30	$15.13K	50,000
May 25, 2023	Gilliland Robertson H.	director	-	A-Award	Buy	50,000	$0.30	$15.13K	50,000
May 25, 2023	Claiborne Cary J	director, officer	Chief Executive Officer	A-Award	Buy	420,000	-	-	1,520,000
May 25, 2023	Claiborne Cary J	director, officer	Chief Executive Officer	A-Award	Buy	300,000	$0.30	$90.75K	300,000
May 25, 2023	Anderson J. Kermit	director	-	A-Award	Buy	50,000	$0.30	$15.13K	50,000

The last insider buy of ADIL was made by Schuyler Kevin on Oct 03 2023, buying 700 shares at $2.74 per share (worth $1.92K).

Adial Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	7	-	-
Q3 2023	1	-	-
Q2 2023	12	-	-
Q4 2022	-	1	-
Q3 2022	5	-	-
Q2 2022	1	-	-
Q1 2022	9	-	-
Q4 2021	8	4	200.00%
Q2 2021	-	1	-
Q1 2021	10	-	-
Q4 2020	5	4	125.00%
Q3 2020	-	1	-
Q2 2020	1	-	-
Q1 2020	14	-	-
Q4 2019	1	1	100.00%
Q1 2019	7	-	-
Q4 2018	16	5	320.00%
Q3 2018	57	15	380.00%
Q1 2018	-	8	-
Q4 2017	-	5	-

7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Adial Pharmaceuticals's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q3 2023	1	-	-
Q2 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	6	1	600.00%
Q2 2021	-	1	-
Q1 2021	-	-	-
Q4 2020	-	-	-
Q3 2020	-	1	-
Q2 2020	-	-	-
Q1 2020	5	-	-
Q4 2019	-	1	-
Q1 2019	4	-	-
Q4 2018	-	-	-
Q3 2018	16	-	-
Q1 2018	-	-	-
Q4 2017	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Adial Pharmaceuticals's stocks.

Adial Pharmaceuticals Peer Ownership

Ticker	Company
HOTH	Hoth Therapeutics, Inc.
AXLA	Axcella Health Inc.
RVPH	Reviva Pharmaceuticals Holdings, Inc.
BPTH	Bio-Path Holdings, Inc.
KTTA	Pasithea Therapeutics Corp.
AEZS	Aeterna Zentaris Inc.
ADTX	Aditxt, Inc.
REVB	Revelation Biosciences, Inc.
RNAZ	TransCode Therapeutics, Inc.
TNXP	Tonix Pharmaceuticals Holding Corp.
DFFN	CervoMed Inc.
VRAX	Virax Biolabs Group Limited
RNXT	RenovoRx, Inc.
NRBO	NeuroBo Pharmaceuticals, Inc.
ONTX	Traws Pharma, Inc.
ATXI	Avenue Therapeutics, Inc.
CBIO	Gyre Therapeutics, Inc.
BNTC	Benitec Biopharma Inc.
ALRN	Aileron Therapeutics, Inc.

ADIL Ownership FAQ

Who Owns Adial Pharmaceuticals?

Adial Pharmaceuticals is owned by institutional shareholders (8.52%), insiders (1.76%), and public (89.72%). The largest institutional shareholder of Adial Pharmaceuticals is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of Adial Pharmaceuticals?

Adial Pharmaceuticals's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, TRUIST FINANCIAL CORP, MORGAN STANLEY, and TWO SIGMA INVESTMENTS, LP. The top five shareholders own together 0% of the company's share outstanding.

How many Adial Pharmaceuticals shareholders are there?

As of Jun 2023, there are 17 institutional shareholders of Adial Pharmaceuticals.

What percentage of Adial Pharmaceuticals is owned by WELLS FARGO & COMPANY/MN?

WELLS FARGO & COMPANY/MN owns 0 shares of Adial Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).

What percentage of Adial Pharmaceuticals is owned by NORTHERN TRUST CORP?

As of Sep 2023, NORTHERN TRUST CORP holds 0 shares of Adial Pharmaceuticals (ADIL), compromising 0% of the company, valued at $0.

What percentage of Adial Pharmaceuticals is owned by TRUIST FINANCIAL CORP?

TRUIST FINANCIAL CORP is the third largest holder of Adial Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).